Reliant Investment Partners’s AbbVie ABBV Stock Holding History

Reliant Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78M	Sell	7,057 -123	-2%	-$26.5K	1.21%	20
2026 Q1	$1.56M	Buy	7,180 +8	+0.1%	+$1.77K	1.29%	17
2025 Q4	$1.64M	Sell	7,172 -200	-3%	-$45.6K	1.29%	15
2025 Q3	$1.72M	Sell	7,372 -135	-2%	-$27.5K	1.35%	15
2025 Q2	$1.39M	Sell	7,507 -177	-2%	-$32.9K	1.22%	16
2025 Q1	$1.61M	Buy	7,684 +177	+2%	+$34.4K	1.64%	14
2024 Q4	$1.33M	Buy	+7,507	New	+$1.38M	1.18%	16

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Reliant Investment Partners's ABBV Position: Q2 2026 in Review

Reliant Investment Partners reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $26.5K and leaving 7,057 shares worth $1.78M. The position accounts for 1.21% of the portfolio, ranked #20.

Reliant Investment Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Reliant Investment Partners held 7,057 shares of AbbVie worth $1.78M as of Q2 2026.
Reliant Investment Partners sold 123 AbbVie shares in Q2 2026, an estimated $26.5K.
AbbVie made up 1.21% of Reliant Investment Partners's portfolio in Q2 2026, its #20 holding.
Reliant Investment Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Reliant Investment Partners's 13F filing for Q2 2026, filed 11 Aug 2026.